Effects of melatonin on depression and cognition function in hemodialyzed patients, A randomized, double-blind, controlled trial
Phase 2
Recruiting
- Conditions
- Chronic kidney disease, Hemodialysis.Chronic kidney disease, stage 5
- Registration Number
- IRCT20110226005914N3
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
They should be hemodialized for at least 3 months and 3 times per week and 4 hours per visit.
They should be fluent in Farsi language .
They should have visual and auditory health to complete the questionnaire.
Exclusion Criteria
Have diabetes type 1 or 2.
Have psychotic disease
Take antidepressant medicationss.
Take anti-anxiety/sedative medications.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression Score in the Beck Questionnaire.Cognitive impairment Score in the MMSE Questionnaire. Timepoint: Before starting the medication and two months after taking Melatonin tablets. Method of measurement: Beck Depression questionnare and MMSE Cognitive Impairment questionnaire.
- Secondary Outcome Measures
Name Time Method